LACOG 0111 – MGH | MGH – International Breast Cancer Collaborative Project: Determination of an Endocrine Responsive Metastatic Breast Cancer Signature.
LACOG 0312 – METASTATIC BC | Metastatic breast cancer in Brazil: characterization of patients and treatments.
LACOG 0414 | Evaluation of the attitude of premenopausal patients with breast cancer to the risk of loss of fertility caused by chemotherapy.
LACOG 0801 – GLICO | A randomized open-label, phase II study of lapatinib/capecitabine or lapatinib/vinorelbine or lapatinib/gemcitabine in subjects with Her2/neu amplified metastatic breast cancer patients progressing after taxanes treatment.
LACOG 0115 – LORELEI | A Phase II Randomized, Double-Blind, Parallel Cohort Study of Neoadjuvant Letrozole + GDC-0032 versus Letrozole + Placebo in Post-Menopausal Women with ER+/HER2- Primary Breast Cancer.
LACOG 0211 – ALK | A clinical and epidemiologic study of EML4-ALK and other ALK fusions genes in lung cancer patients in Latin American.
Parsimony | Non-small-cell lung cancer (NSCLC) stage III treated with concurrent chemoradiation followed or not by consolidation chemotherapy.
LACOG 0213 – AUGMENT | A Phase 3, Double-blind, Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Placebo in Subjects With Relapsed/RefractoryIndolent Lymphoma.
LACOG 0214 – FINEP | Validation of 99mTc- EDDA – HYNIC -TOC kits for diagnosis of neuroendocrine tumors
